138 related articles for article (PubMed ID: 38025797)
1. Association of Cerebrovascular Imaging Biomarkers, Depression, and Anxiety, with Mild Cognitive Impairment.
Vassilaki M; Syrjanen JA; Krell-Roesch J; Graff-Radford J; Vemuri P; Scharf EL; Machulda MM; Fields JA; Kremers WK; Lowe VJ; Jack CR; Knopman DS; Petersen RC; Geda YE
J Alzheimers Dis Rep; 2023; 7(1):1237-1246. PubMed ID: 38025797
[TBL] [Abstract][Full Text] [Related]
2. Cortical β-amyloid burden, neuropsychiatric symptoms, and cognitive status: the Mayo Clinic Study of Aging.
Krell-Roesch J; Vassilaki M; Mielke MM; Kremers WK; Lowe VJ; Vemuri P; Machulda MM; Christianson TJ; Syrjanen JA; Stokin GB; Butler LM; Traber M; Jack CR; Knopman DS; Roberts RO; Petersen RC; Geda YE
Transl Psychiatry; 2019 Mar; 9(1):123. PubMed ID: 30923322
[TBL] [Abstract][Full Text] [Related]
3. Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment.
Newton P; Tchounguen J; Pettigrew C; Lim C; Lin Z; Lu H; Moghekar A; Albert M; Soldan A;
J Alzheimers Dis; 2023; 92(1):323-339. PubMed ID: 36744337
[TBL] [Abstract][Full Text] [Related]
4. White matter hyperintensities and cognition across different Alzheimer's biomarker profiles.
Lam S; Lipton RB; Harvey DJ; Zammit AR; Ezzati A;
J Am Geriatr Soc; 2021 Jul; 69(7):1906-1915. PubMed ID: 33891712
[TBL] [Abstract][Full Text] [Related]
5. Assessing the Role of Past Depression in Patients with Mild Cognitive Impairment, with and without Biomarkers for Alzheimer's Disease.
Golas AC; Salwierz P; Rajji TK; Bowie CR; Butters MA; Fischer CE; Flint AJ; Herrmann N; Mah L; Mulsant BH; Pollock BG; Taghdiri F; Wang W; Tartaglia MC;
J Alzheimers Dis; 2023; 92(4):1219-1227. PubMed ID: 36911939
[TBL] [Abstract][Full Text] [Related]
6. Increased regional white matter hyperintensity volume in objectively-defined subtle cognitive decline and mild cognitive impairment.
Calcetas AT; Thomas KR; Edmonds EC; Holmqvist SL; Edwards L; Bordyug M; Delano-Wood L; Brickman AM; Bondi MW; Bangen KJ; For The Alzheimer's Disease Neuroimaging Initiative
Neurobiol Aging; 2022 Oct; 118():1-8. PubMed ID: 35809348
[TBL] [Abstract][Full Text] [Related]
7. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
Nolze-Charron G; Mouiha A; Duchesne S; Bocti C;
J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychiatric symptoms and white matter hyperintensities in older adults without dementia.
Liampas I; Siokas V; Zoupa E; Kyriakoulopoulou P; Stamati P; Provatas A; Tsouris Z; Tsimourtou V; Lyketsos CG; Dardiotis E
Int Psychogeriatr; 2024 Apr; ():1-13. PubMed ID: 38639110
[TBL] [Abstract][Full Text] [Related]
9. Mid- and Late-Life Physical Activity and Neuropsychiatric Symptoms in Dementia-Free Older Adults: Mayo Clinic Study of Aging.
Krell-Roesch J; Syrjanen JA; Bezold J; Trautwein S; Barisch-Fritz B; Kremers WK; Fields JA; Scharf EL; Knopman DS; Stokin GB; Petersen RC; Jekauc D; Woll A; Vassilaki M; Geda YE
J Neuropsychiatry Clin Neurosci; 2023; 35(2):133-140. PubMed ID: 36464975
[TBL] [Abstract][Full Text] [Related]
10. Anxiety, Depression, and Apathy as Predictors of Cognitive Decline in Patients With Parkinson's Disease-A Three-Year Follow-Up Study.
Toloraia K; Meyer A; Beltrani S; Fuhr P; Lieb R; Gschwandtner U
Front Neurol; 2022; 13():792830. PubMed ID: 35211081
[TBL] [Abstract][Full Text] [Related]
11. White matter hyperintensities and neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease.
Misquitta K; Dadar M; Louis Collins D; Tartaglia MC;
Neuroimage Clin; 2020; 28():102367. PubMed ID: 32798911
[TBL] [Abstract][Full Text] [Related]
12. White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts.
Dadar M; Mahmoud S; Zhernovaia M; Camicioli R; Maranzano J; Duchesne S;
Neuroimage Clin; 2022; 36():103204. PubMed ID: 36155321
[TBL] [Abstract][Full Text] [Related]
13. White matter hyperintensities and mild behavioral impairment: Findings from the MEMENTO cohort study.
Miao R; Chen HY; Robert P; Smith EE; Ismail Z;
Cereb Circ Cogn Behav; 2021; 2():100028. PubMed ID: 36324720
[TBL] [Abstract][Full Text] [Related]
14. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
[TBL] [Abstract][Full Text] [Related]
15. FDG-PET and Neuropsychiatric Symptoms among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging.
Krell-Roesch J; Ruider H; Lowe VJ; Stokin GB; Pink A; Roberts RO; Mielke MM; Knopman DS; Christianson TJ; Machulda MM; Jack CR; Petersen RC; Geda YE
J Alzheimers Dis; 2016 Jul; 53(4):1609-16. PubMed ID: 27447426
[TBL] [Abstract][Full Text] [Related]
16. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
Low A; Ng KP; Chander RJ; Wong B; Kandiah N
J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
[TBL] [Abstract][Full Text] [Related]
17. A longitudinal investigation of Aβ, anxiety, depression, and mild cognitive impairment.
Pink A; Krell-Roesch J; Syrjanen JA; Vassilaki M; Lowe VJ; Vemuri P; Stokin GB; Christianson TJ; Kremers WK; Jack CR; Knopman DS; Petersen RC; Geda YE
Alzheimers Dement; 2022 Oct; 18(10):1824-1831. PubMed ID: 34877794
[TBL] [Abstract][Full Text] [Related]
18. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
[TBL] [Abstract][Full Text] [Related]
19. Combined Score of Perivascular Space Dilatation and White Matter Hyperintensities in Patients with Normal Cognition, Mild Cognitive Impairment, and Dementia.
Zdanovskis N; Platkājis A; Kostiks A; Šneidere K; Stepens A; Naglis R; Karelis G
Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888606
[No Abstract] [Full Text] [Related]
20. Association between white matter hyperintensity load and grey matter atrophy in mild cognitive impairment is not unidirectional.
Vipin A; Wong BYX; Kumar D; Low A; Ng KP; Kandiah N
Aging (Albany NY); 2021 Apr; 13(8):10973-10988. PubMed ID: 33861727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
